Previous 10 | Next 10 |
Pfizer (NYSE: PFE) was all over the headlines this week after Monday's promising results regarding the coronavirus vaccines it is co-developing along with BioNTech (NASDAQ: BNTX) . On top of that, the U.S. government said it will pay the companies $1.95 billion to secure as many as 600 ...
Investors were in a frenzy Monday morning after Pfizer (NYSE: PFE) announced early positive results from a potential coronavirus vaccine it is studying in partnership with BioNTech in a phase 1/2 trial held in Germany. Pfizer is collaborating with BioNTech on four potential vaccines in a...
HERTFORDSHIRE, England and PITTSBURGH , July 22, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its second quarter 2020 financial results on Thurs., Aug. 6 , before the open of the U.S. financial markets. The comp...
Just because we are in a recession doesn't mean it's a bad time to invest in stocks. After all, buying shares of great companies -- and holding these shares for long periods -- remains one of the best ways to accumulate wealth. Of course, before putting your money in the stock market, it's essen...
The second half of the year could provide some solid wins for investors in the cancer therapeutics market. In recent years, Wall Street has flocked to many of these biotechnology companies because of their potential to deliver cutting-edge treatments and generate long-term returns. As cancer ...
HERTFORDSHIRE, England , PITTSBURGH and NEW YORK , July 9, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Upjohn, a division of Pfizer, today unveiled the logo and branding for VIATRIS ™ , the new company that will be formed by combining Mylan and Upjohn. Experience...
Mylan N.V. (NASDAQ: MYL ) and collaboration partner Fujifilm Kyowa Kirin Biologics Co., Ltd. ( OTCPK:FUJIF ) announce the FDA nod for Hulio (adalimumab-fkjp), a biosimilar to AbbVie's (NYSE: ABBV ) top seller Humira. More news on: Mylan, Inc., FUJIFILM Holdings Corporation, AbbVie Inc., ...
HERTFORDSHIRE, England and PITTSBURGH and TOKYO , July 9, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hulio ® (adalimumab-fkjp), a bio...
AbbVie (NYSE: ABBV) and Biogen (NASDAQ: BIIB) are two drugmakers that have moved in opposite directions on the stock market of late. While AbbVie has rebounded nicely from the market crash since late March -- with its stock up by 11.7% year to date as of this writing -- shares of Biogen ...
HERTFORDSHIRE, England and PITTSBURGH , July 7, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...